Richard S Casten is Chief Financial Officer of Baudax Bio, Inc.. Currently has a direct ownership of 200,000 shares of BXRX, which is worth approximately $2,000. The most recent transaction as insider was on Aug 20, 2021, when has been sold 50,000 shares (Common Stock) at a price of $0.51 per share, resulting in proceeds of $25,500. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 200K
0% 3M change
0% 12M change
Total Value Held $2,000

Richard S Casten Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 20 2021
BUY
Open market or private purchase
$25,500 $0.51 p/Share
50,000 Added 20.0%
200,000 Common Stock
May 14 2021
BUY
Open market or private purchase
$19,750 $0.79 p/Share
25,000 Added 14.29%
150,000 Common Stock
Mar 15 2021
BUY
Open market or private purchase
$35,250 $1.41 p/Share
25,000 Added 16.67%
125,000 Common Stock
Mar 08 2021
BUY
Grant, award, or other acquisition
-
100,000 Added 50.0%
100,000 Common Stock
RSC

Richard S Casten

Chief Financial Officer
Malvern, PA

Track Institutional and Insider Activities on BXRX

Follow Baudax Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BXRX shares.

Notify only if

Insider Trading

Get notified when an Baudax Bio, Inc. insider buys or sells BXRX shares.

Notify only if

News

Receive news related to Baudax Bio, Inc.

Track Activities on BXRX